ArticleFrontiers in plant science2017
Article in Frontiers in plant science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 54 citations in OpenAlex.
- A Sustainable Strategy for Marker-Assisted Selection (MAS) Applied in Grapevine (Plants (Basel, Switzerland) · 2024Article
- Mining of Minor Disease Resistance Genes inInternational journal of molecular sciences · 2023Article
- Surface wax in the ancestral grapevine Vitis sylvestris correlate with partial resistance to Powdery Mildew.BMC plant biology · 2023Article
- A Compendium for Novel Marker-Based Breeding Strategies in Eggplant.Plants (Basel, Switzerland) · 2023Review
- Semi-Targeted Profiling of the Lipidome Changes Induced byInternational journal of molecular sciences · 2023Article
- Towards Marker-Assisted Breeding for Black Rot Bunch Resistance: Identification of a Major QTL in the Grapevine Cultivar 'Merzling'.International journal of molecular sciences · 2023Article
- Secondary and primary metabolites reveal putative resistance-associated biomarkers againstFrontiers in plant science · 2023Article
- Powdery Mildew Resistance Genes in Vines: An Opportunity to Achieve a More Sustainable Viticulture.Pathogens (Basel, Switzerland) · 2022Review
- Gene-Based Resistance toGenes · 2022Review
- Characterization of physiological and antioxidant responses inFrontiers in plant science · 2022Article
- Genetic changes in the genusFrontiers in plant science · 2022Review
- Construction of a high-density genetic map and detection of a major QTL of resistance to powdery mildew (Erysiphe necator Sch.) in Caucasian grapes (Vitis vinifera L.).BMC plant biology · 2021Article
- Confirmation and Fine Mapping of the Resistance LocusPlants (Basel, Switzerland) · 2020Article
- Recent advances in biotechnological studies on wild grapevines as valuable resistance sources for smart viticulture.Molecular biology reports · 2020Review
- High-density linkage maps and loci for berry color and flower sex in muscadine grape (Vitis rotundifolia).TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2019Article
- Biosynthetic Gene Pyramiding Leads to Ascorbate Accumulation with Enhanced Oxidative Stress Tolerance in Tomato.International journal of molecular sciences · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal pathogens are the cause of the most common diseases in grapevine and among them powdery mildew represents a major focus for disease management. Different strategies for introgression of resistance in grapevine are currently undertaken in breeding programs. For example, introgression of several resistance genes (R) from different sources for making it more durable and also strengthening the plant defense response. Taking this into account, we cross-pollinated P09-105/34, a grapevine plant carrying both
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.